|1.||Baker, James R: 10 articles (12/2015 - 11/2002)|
|2.||Kannan, Rangaramanujam M: 5 articles (08/2014 - 03/2006)|
|3.||Shi, Xiangyang: 5 articles (05/2013 - 07/2005)|
|4.||Thomas, Thommey P: 4 articles (08/2015 - 09/2005)|
|5.||Zhang, Lihong: 4 articles (05/2015 - 01/2010)|
|6.||Jiang, Yanyan: 4 articles (05/2015 - 01/2010)|
|7.||Majoros, István J: 4 articles (03/2006 - 07/2005)|
|8.||Wagner, Ernst: 3 articles (08/2015 - 08/2010)|
|9.||Kotlyar, Alina: 3 articles (08/2015 - 12/2005)|
|10.||Ogris, Manfred: 3 articles (08/2015 - 08/2010)|
01/01/2000 - "This study demonstrates in vivo effectiveness of a nonviral vector system, Epstein-Barr virus (EBV)-based plasmid vector coupled with polyamidoamine (PAMAM) dendrimer (EBV/polyplex), in suicide gene therapy of cancer. "
01/01/2015 - "We present predictive models developed using 103 PAMAM dendrimer cytotoxicity values that were extracted from twelve cancer nanomedicine journal articles. "
08/17/2010 - "Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery."
11/01/2009 - "Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells."
09/01/2007 - "These results show that PAMAM dendrimer-modified MNPs may be a good gene delivery system and have potential applications in cancer therapy and molecular imaging diagnosis."
08/01/2014 - "Using a mouse model of intrauterin inflammation leading to neuroinflammation in the fetus, these investigators demonstrate that intra-amniotic delivery of hydroxyl polyamidoamine (PAMAM) dendrimer (G4-OH)-based nanomedicines may provide an effective method in preventing this complication."
08/01/2014 - "We explore whether hydroxyl polyamidoamine (PAMAM) dendrimer (G4-OH)-based nanomedicines can be delivered to the fetus by intra-amniotic administration, in a mouse model of intrauterine inflammation. "
11/01/2011 - "We have shown that a generation (G) 3.5 polyamidoamine (PAMAM) dendrimer that was partially glycosylated with glucosamine inhibits TLR4-MD-2-LPS induced inflammation in a rabbit model of tissue scaring. "
08/01/2015 - "In this study, we examine the therapeutic efficacy of G5 PAMAM dendrimer methotrexate conjugates (G5-MTX) that also have folic acid (FA) conjugated to the G5-MTX (G5-FA-MTX) to target inflammation-activated folate receptors overexpressing macrophages. "
01/01/2011 - "A PAMAM dendrimer fully substituted by click chemistry on its peripheral groups with 64 moieties of a nucleoside agonist was shown to be potent and selective in binding to the mouse A3AR and effective in cardioprotection in an isolated mouse heart model of ischemia/reperfusion (I/R) injury. "
12/12/2011 - "This study successfully evaluated gene delivery and transfection toward rat C6 glioma cell lines mediated by intrinsic blue fluorescent poly(amido amine) (PAMAM) dendrimer. "
05/01/2010 - "The current study demonstrates the suitability of folate-PAMAM dendrimer conjugates for efficient EGFR ASODN delivery into glioma cells, wherein they release the ASODN from the FA-PAMAM to knock down EGFR expression in C6 glioma cells, both in vitro and in vivo. "
10/01/2013 - "Comparative study of microtubule inhibitors--estramustine and natural podophyllotoxin conjugated PAMAM dendrimer on glioma cell proliferation."
03/10/2013 - "Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma."
|5.||Prostatic Neoplasms (Prostate Cancer)
12/15/2015 - "Ultrasensitive electrochemical immunosensor for PSA biomarker detection in prostate cancer cells using gold nanoparticles/PAMAM dendrimer loaded with enzyme linked aptamer as integrated triple signal amplification strategy."
03/05/2012 - "Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer."
08/01/2009 - "Altogether, TEA core PAMAM dendrimer-mediated siRNA delivery, in combination with RNAi that specifically targets Hsp27, may constitute a promising approach for combating castrate-resistant prostate cancer, for which there is no efficacious treatment."
03/05/2012 - "In the present study, we demonstrate that a triethanolamine (TEA)-core PAMAM dendrimer of generation 5 (G(5)) is able to deliver sticky siRNAs bearing complementary A(n)/T(n) 3'-overhangs effectively to a prostate cancer model in vitro and in vivo and produce potent gene silencing of the heat shock protein 27, leading to a notable anticancer effect. "
|2.||Folic Acid (Vitamin M)
|5.||Transferrin (beta 2 Transferrin)
|2.||Quantum Dots (Quantum Dot)
|3.||Photochemotherapy (Photodynamic Therapy)